Who
Andrew D.C. LaFrence
Director
Company insider
Files Form 4 as: Director, SkyWater Technology; Chief Financial Officer, Nortech Systems; Chief Financial Officer, KORU Medical Systems; Chief Financial Officer, Vyant Bio.
In numbers
- Trades disclosed
- 20
- Buys
- 3
- Sells
- 0
- Bought
- $30K
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 1
- First trade
- 30 Mar 2021
- Last trade
- 31 Jul 2026
- Last filed
- 31 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Jul 2026filed 31 Jul 2026 | SkyWater TechnologySemiconductors | SEC FORM 4 Code D | —11,428 | filing |
| 31 Jul 2026filed 31 Jul 2026 | SkyWater TechnologySemiconductors | SEC FORM 4 Code D | —4,304 | filing |
| 31 Jul 2026filed 31 Jul 2026 | SkyWater TechnologySemiconductors | SEC FORM 4 Code D | —11,428 | filing |
| 31 Jul 2026filed 31 Jul 2026 | SkyWater TechnologySemiconductors | SEC FORM 4 Code D | —4,304 | filing |
| 10 Jun 2026filed 12 Jun 2026 | SkyWater TechnologySemiconductors | SEC FORM 4 Code A | —4,304 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | SkyWater TechnologySemiconductors | SEC FORM 4 Code A | —4,304 at $0.00 | filing |
| 21 May 2025filed 23 May 2025 | SkyWater TechnologySemiconductors | SEC FORM 4 Code A | $100K11,428 at $8.75 | filing |
| 4 Dec 2023filed 5 Dec 2023 | NSYS Nortech Systemsoption or derivative · Electronic Components & EMS | SEC FORM 4 Code A | $362K40,000 at $9.04 | filing |
| 15 Jul 2023filed 18 Jul 2023 | KRMD KORU Medical Systemsoption or derivative · Medical Devices | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 15 Mar 2022filed 17 Mar 2022 | Vyant Biooption or derivative | SEC FORM 4 Code A | —110,000 at $0.00 | filing |
| 23 Nov 2021filed 29 Dec 2021 | Vyant Bio | SEC FORM 4 Bought | $10K5,000 at $2.00 | filing |
| 23 Nov 2021filed 24 Nov 2021 | Vyant Bio | SEC FORM 4 Bought | $10K5,000 at $2.00 | filing |
| 20 May 2021filed 21 May 2021 | Vyant Bio | SEC FORM 4 Bought | $9,8403,000 at $3.28 | filing |
| 30 Mar 2021filed 13 Jul 2021 | Vyant Bio | SEC FORM 4 Code J | —29,292 | filing |
| 30 Mar 2021filed 13 Jul 2021 | Vyant Bio | SEC FORM 4 Code J | —26,825 | filing |
| 30 Mar 2021filed 1 Apr 2021 | Vyant Biooption or derivative | SEC FORM 4 Code J | —172,944 at $0.00 | filing |
| 30 Mar 2021filed 1 Apr 2021 | Vyant Biooption or derivative | SEC FORM 4 Code J | —38,868 at $0.00 | filing |
| 30 Mar 2021filed 1 Apr 2021 | Vyant Biooption or derivative | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 30 Mar 2021filed 1 Apr 2021 | Vyant Bio | SEC FORM 4 Code J | —29,336 | filing |
| 30 Mar 2021filed 1 Apr 2021 | Vyant Bio | SEC FORM 4 Code J | —26,866 | filing |
News
No headline names them, or the companies they trade most, lately.